Cannabinoid Articles from PubMed
Below are links to articles from PubMed (PubMed is the NIH Open Access Database) about the effects of cannabinoids and the human body. These articles are property of the owners which are listed on each page.
- Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.
- Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
- The endocannabinoid system as an emerging target of pharmacotherapy.
- The therapeutic potential of cannabis and cannabinoids.
- Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
- Practical considerations in medical cannabis administration and dosing.
- Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
- Cannabidiol: a promising drug for neurodegenerative disorders?
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.
- Hypnotic and antiepileptic effects of cannabidiol.
- Chronic administration of cannabidiol to healthy volunteers and epileptic patients.
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
- Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.
- Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
- Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors.
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.
- Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
- Is the cardiovascular system a therapeutic target for cannabidiol?
- Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients.
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
- Cannabidiol in inflammatory bowel diseases: a brief overview.
- Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
- Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
- Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.
- Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.
- Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.
- Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
- Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression.
- The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.